Fortunato v. Akebia Therapeutics, Inc., et al. (Lawyers Weekly No. 12-012-17)
State courts have concurrent jurisdiction over federal Securities Act class actions. A company's failure to disclose interim clinical trial results is not actionable when the company could not lawfully have known those results.